Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ENSG00000279310 is annotated in the Ensembl database as a long non-coding RNA (lncRNA), specifically referred to as REN in recent research[1]. lncRNAs do not encode proteins; instead, they are implicated in regulatory roles at the transcriptional and post-transcriptional level. REN (ENSG00000279310) has been reported as a ventrally expressed lncRNA with a gradient of gene expression in certain tissues, but there is currently no evidence that it functions as a therapeutic target, receptor, enzyme, transporter, or is involved in known drug interactions or disease mechanisms[1]. This means it does not fit the canonical target classifications (e.g., receptor, enzyme, transporter, etc.), and the use of this identifier as a therapeutic target is likely incorrect[1].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on REN (lncRNA ENSG00000279310) (REN).